Eulerpool/
Stock/
Genmab A/S/
Current Assets

Genmab A/S Current Assets

GMAB.CO

The Current Assets of Genmab A/S (GMAB.CO) as of Jul 21, 2026 is 2.89 B USD. In the previous year, Current Assets was 3.87 B USD — a change of -25.40% (lower).

Get this data via API

Financial Data API

Current Assets

2.89 BUSD

YoY

-25.40%

Last updated: Jul 21, 2026

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE

Current Assets of Genmab A/S is 2026 2.89 B USD. Current Assets of Genmab A/S was 2025 3.87 B USD. It decreases by -25.40% lower compared to the previous year.

Genmab A/S Total Assets Genmab A/S Current Liabilities Genmab A/S Current Ratio Genmab A/S Working Capital

Access this data via the Eulerpool API

Docs Get Free API Key

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Current Assets of Genmab A/S is 2.89 B USD in 2026.

Current Assets of Genmab A/S changed from 3.87 B USD to 2.89 B USD, representing a -25.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Genmab A/S historically and in real time.

Access this data via the Eulerpool API

Docs Get Free API Key